A study by Wargo et al. examined the human gut microbiota and metabolites of metastatic melanoma patients who received anti-PD-1 therapy using 16S rRNA and whole genome shotgun sequencing (73). The gene discussed is PDCD1; the disease is metastatic melanoma.